MPLT
MapLight Therapeutics, Inc.Healthcare·Biotechnology
$29.31
$23M market cap
Revenue
$0.0M
Free Cash Flow
$-98.4M
Rev Growth
+0.0%
FCF Margin
0.0%
P/FCF
--
EV/FCF
--
Fwd EV/EBITDA
--
Fair Value
--
Upside
--
MapLight Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company for patients suffering from debilitating central nervous system disorders. The company's products include ML-007C-MA, a fixed-dose combination of an M 1 /M 4 muscarinic agonist for the treatment of schizophrenia and Alzheimer's disease psychosis; ML-004 for the treatment of social communication deficit and/or irritability in autism spectrum disorder; ML-021 for the treatment of motor deficits in Parkinson's diseas
2-Year Price History
$28.75+69.9%
Quarterly Financials & Projections
Quarterly Waterfall ($ M)
| Period | Rev | EBITDA | OpIn | NI | OCF | FCF | CapEx | Cash | Debt | Shares | ROIC | IntCov | EV/EBITDA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Act | 2026-Q1 | 0.0 | -64.3 | -64.5 | -60.7 | -51.2 | -51.2 | -0.0 | 310.1 | 5.6 | 45.3 | -275.3% | -- | -- |
| Act | 2025-Q4 | 0.0 | -83.2 | -83.4 | -79.6 | -46.8 | -47.2 | -0.4 | 305.1 | 5.8 | 44.0 | -215.5% | -- | -- |
Valuation & Metrics
Market Stats
Price$29.31
Market Cap$23M
Enterprise Value$-281M
P/S Ratio0.0x
P/FCF--
EV/FCF--
FCF Margin (TTM)0.0%
FCF Yield-425.4%
Dividend Yield (TTM)--
Annual Dilution0.0%
CurrencyUSD
TTM Financial Snapshot
Revenue$0.0M
Net Income$-140.2M
Free Cash Flow$-98.4M
Revenue Growth (YoY)+0.0%
EBITDA Margin0.0%
Net Margin0.0%
FCF Margin0.0%
CapEx % of Revenue0.0%
SBC % of Revenue0.0%
ROIC-245.4%
WC Change % Rev0.0%
Interest Coverage--
Forward Outlook & Risk
Short Interest
Short % of Float--
Short Shares1.7M
Days to Cover4.9
Change (vs Prior)+3.7%
Need at least 2 settlement dates for chart
Employees
Headcount109
Revenue / Employee$0
Gross Profit / Employee$-2,771
Cash Runway
37.8months
WATCH
Institutional Ownership
Headline & net flow
NEUTRAL
Net flow · —still filing
No float data — flow unavailable.
Ownership composition
Active
1915.9%(+342.6% YoY)
71 filers
hedge / family / endowment
Retail funds
—
Fidelity, Schwab, 401(k)
Passive
293.2%(+84.3% YoY)
8 filers
Vanguard, iShares, SPDR
Market makers
0.2%(-0.0% YoY)
1 filers
Citadel, Susquehanna
Insiders
—
Form 4 — latest per insider
ActiveRetail fundsPassiveMarket makersRetail direct
Top holders
| Fund | $ value | Cost basis | Δ QoQ | Δ YoY | α life | Fund AUM |
|---|---|---|---|---|---|---|
| Novo Holdings A/S | $74.9M | $17.57 | +$0 | +$74.9M | -3.3% | $1.23B |
| FCPM III SERVICES B.V. | $65.6M | $17.57 | +$0 | +$65.6M | -3.1% | $722M |
| T. Rowe Price Investment Management, Inc. | $57.0M | $17.57 | +$56K | +$57.0M | -1.3% | $145.22B |
| GOLDMAN SACHS GROUP INC | $40.6M | $17.65 | +$1.2M | +$40.6M | -0.2% | $760.93B |
| BlackRock, Inc.Passive | $27.2M | $18.07 | +$5.0M | +$27.2M | -0.2% | $5.69T |
| Blue Owl Capital Holdings LP | $20.5M | $19.43 | +$13.8M | +$20.5M | -2.3% | $372M |
| Nan Fung Group Holdings Ltd | $19.7M | $17.57 | +$0 | +$19.7M | -4.2% | $120M |
| 5AM Venture Management, LLC | $19.3M | $17.57 | +$0 | +$19.3M | +0.9% | $360M |
| Sanofi | $18.5M | $17.57 | +$0 | +$18.5M | +3.8% | $336M |
| VANGUARD CAPITAL MANAGEMENT LLCPassive | $14.6M | $20.33 | +$14.6M | +$14.6M | — | $4.04T |
| Pivotal bioVenture Partners Investment Advisor LLC | $12.4M | $17.57 | +$0 | +$12.4M | +1.7% | $280M |
| Velan Capital Investment Management LP | $10.0M | $17.57 | −$598K | +$10.0M | -5.5% | $160M |
| GEODE CAPITAL MANAGEMENT, LLCPassive | $9.8M | $18.10 | +$1.9M | +$9.8M | +2.3% | $1.61T |
| Siren, L.L.C. | $9.1M | $17.57 | +$0 | +$9.1M | +6.1% | $3.61B |
| Vestal Point Capital, LP | $8.5M | $17.80 | +$712K | +$8.5M | -0.1% | $3.58B |
| ADAR1 Capital Management, LLC | $7.6M | $20.33 | +$7.6M | +$7.6M | +8.3% | $1.64B |
| BAKER BROS. ADVISORS LP | $7.4M | $17.57 | +$0 | +$7.4M | -0.5% | $16.13B |
| STATE STREET CORPPassive | $6.9M | $18.46 | +$2.2M | +$6.9M | -0.2% | $2.89T |
| Freestone Grove Partners LP | $6.4M | $18.71 | +$2.6M | +$6.4M | +1.2% | $13.77B |
| BNP Paribas Asset Management Holding S.A. | $5.4M | $18.81 | +$2.4M | +$5.4M | -1.1% | $85.48B |
Cost basis is a volume-weighted estimate from accumulation periods within our 13F history; holders who built their position before our window started will show a stale basis. % above the cost basis is the unrealized gain at the current price.
Trading behavior
Smart-money alpha (lifetime, %/qtr)BEARISH
Holders
-1.14%
avg per quarter
Holders (ex-self)
-1.22%
excl. this stock
Buyers (this Q)
-0.20%
47 buyers · $0.11B in
Sellers (this Q)
+1.42%
13 sellers · $0.00B out
alpha coverage: 96% of $ has a lifetime-alpha record
Holder behavior (holder profile)source: holder
On big dips (−10%+)
+1.9%
how holders react when this stock falls
On quiet Qs
-3.5%
−10% to +10% baseline
On rallies (+10%+)
+3.4%
how they react when this stock rises
Holders' portfolio flow this Q
-3.6%
outflows — trims may be forced
Sellers' portfolio flow this Q
-10.4%
Sellers shed AUM broadly — partly forced.
Biggest decreases this quarter
PERCEPTIVE ADVISORS LLCexited−$9.7MJain Global LLCexited−$5.8MCITADEL ADVISORS LLCexited−$3.3MAMERIPRISE FINANCIAL INCexited−$1.2MDIADEMA PARTNERS LPexited−$1.1MORBIMED ADVISORS LLCexited−$952KMARSHALL WACE, LLPexited−$697KVelan Capital Investment Management LP−$598Kα-5.5Persistent Asset Partners Ltdexited−$382KOXFORD ASSET MANAGEMENT LLPexited−$312K
New buyers this quarter
Top-5 holders · 52.8%
Novo Holdings A/S--
FCPM III SERVICES B.V.--
T. Rowe Price Investment Management, Inc.--
GOLDMAN SACHS GROUP INC--
BlackRock, Inc.--
Top Holders Over Time
5-year share-count history (top 10 holders by peak, incl. exited) + price
hover the chart for per-quarter detailprice (right axis)
Novo Holdings A/S3.7MFCPM III SERVICES B.V.3.2MT. Rowe Price Investment Management, Inc.2.8MGOLDMAN SACHS GROUP INC2.0MBlue Owl Capital Holdings LP1.0MNan Fung Group Holdings Ltd971K5AM Venture Management, LLC950KSanofi912KPivotal bioVenture Partners Investment Advisor LLC611KVelan Capital Investment Management LP493K
Related Stocks
Investors who own this also own
Stocks held by the same active managers as this one, ranked by score — how much more often these appear together than random chance (1× = baseline). Excludes index ETFs and market makers; minimum 3 shared holders.
Analyst Coverage
Analyst Coverage
Price Targets
Last Quarter (2 analysts)$44.005010.0%
Last Year (6 analysts)$35.332050.0%
Current Price$29.31
Corporate
Order Flow (FINRA, ~3w lag)
7.4%retail+0.4pp
25.6%dark-1.6pp
week of 2026-04-13
Off-exchange volume from FINRA. Retail = non-ATS (wholesaler PFOF + broker internalization). Dark = ATS (dark-pool crossing networks, institutional). Lit-exchange = remainder.